Enhancement by chlordiazepoxide of catalepsy induced in rats by intravenous or intrapallidal injections of enantiomeric cannabinoids

Roger Guy Pertwee, A P Wickens

Research output: Contribution to journalArticle

65 Citations (Scopus)

Abstract

The cataleptic response of rats to (-)-delta-9-tetrahydrocannabinol (delta-9-THC), measured using a bar test, was enhanced by subcutaneous pretreatment with chlordiazepoxide (10 mg/kg). Significant potentiation was observed when the cannabinoid was administered peripherally (0.1-1.0 mg/kg i.v.) and when it was injected bilaterally into sites in or very near the posterior medial region of the globus pallidus (30-mu-g). Similar results were obtained with (-)-11-hydroxy-delta-8-dimethylheptyl-THC (0.005 to 0.02 mg/kg i.v. and 3, 10 or 30-mu-g intracerebrally). However, the (+) isomer of the 11-hydroxy compound was inactive in the presence and absence of chlordiazepoxide. It was also found that chlordiazepoxide (10 mg/kg s.c.) enhanced the cataleptic response to the GABA agonist, THIP (0.25-mu-g), injected bilaterally into sites located in or very near the globus pallidus and that the cataleptic response to delta-9-THC (1 mg/kg i.v.) could be potentiated by chlordiazepoxide (50-mu-g), when this was injected into similar sites in the brain. The results support the hypothesis that the cataleptic response to cannabinoids is mediated by gamma-aminobutyric acid. They also provide evidence that cannabinoids can produce catalepsy by interacting with tissue in the vicinity of the globus pallidus and that the ability to interact in this way depends on the conformation of the cannabinoid molecule.

Original languageEnglish
Pages (from-to)237-244
Number of pages8
JournalNeuropharmacology
Volume30
Issue number3
DOIs
Publication statusPublished - Mar 1991

Keywords

  • GLOBUS PALLIDUS
  • BENZODIAZEPINES
  • GAMMA-AMINOBUTYRIC ACID
  • (+)-11-HYDROXY-DELTA-8-DIMETHYLHEPTYL-TETRAHYDROCANNABINOL
  • (-)-11-HYDROXY-DELTA-8-DIMETHYLHEPTYL-TETRAHYDROCANNABINOL
  • (-)-DELTA-9-TETRAHYDROCANNABINOL
  • BENZODIAZEPINE RECEPTORS
  • MICE
  • DELTA-9-TETRAHYDROCANNABINOL
  • globus pallidus
  • benzodiazepines
  • gamma-aminobutyric acid
  • (+)-11-hydroxy-delta-8-dimethylheptyl-tetrahydrocannabinol
  • (-)-11-hydroxy-delta-8-dimethylhrptyl-tetrahydrocannabinol
  • (-)-delta-9-tetrahydrocannabinol
  • benzodiazepine receptors
  • mice
  • delta-9-tetrahydrocannabinol

Cite this

Enhancement by chlordiazepoxide of catalepsy induced in rats by intravenous or intrapallidal injections of enantiomeric cannabinoids. / Pertwee, Roger Guy; Wickens, A P .

In: Neuropharmacology, Vol. 30, No. 3, 03.1991, p. 237-244.

Research output: Contribution to journalArticle

@article{8e46837db4604cc0824a096dd38905ba,
title = "Enhancement by chlordiazepoxide of catalepsy induced in rats by intravenous or intrapallidal injections of enantiomeric cannabinoids",
abstract = "The cataleptic response of rats to (-)-delta-9-tetrahydrocannabinol (delta-9-THC), measured using a bar test, was enhanced by subcutaneous pretreatment with chlordiazepoxide (10 mg/kg). Significant potentiation was observed when the cannabinoid was administered peripherally (0.1-1.0 mg/kg i.v.) and when it was injected bilaterally into sites in or very near the posterior medial region of the globus pallidus (30-mu-g). Similar results were obtained with (-)-11-hydroxy-delta-8-dimethylheptyl-THC (0.005 to 0.02 mg/kg i.v. and 3, 10 or 30-mu-g intracerebrally). However, the (+) isomer of the 11-hydroxy compound was inactive in the presence and absence of chlordiazepoxide. It was also found that chlordiazepoxide (10 mg/kg s.c.) enhanced the cataleptic response to the GABA agonist, THIP (0.25-mu-g), injected bilaterally into sites located in or very near the globus pallidus and that the cataleptic response to delta-9-THC (1 mg/kg i.v.) could be potentiated by chlordiazepoxide (50-mu-g), when this was injected into similar sites in the brain. The results support the hypothesis that the cataleptic response to cannabinoids is mediated by gamma-aminobutyric acid. They also provide evidence that cannabinoids can produce catalepsy by interacting with tissue in the vicinity of the globus pallidus and that the ability to interact in this way depends on the conformation of the cannabinoid molecule.",
keywords = "GLOBUS PALLIDUS, BENZODIAZEPINES, GAMMA-AMINOBUTYRIC ACID, (+)-11-HYDROXY-DELTA-8-DIMETHYLHEPTYL-TETRAHYDROCANNABINOL, (-)-11-HYDROXY-DELTA-8-DIMETHYLHEPTYL-TETRAHYDROCANNABINOL, (-)-DELTA-9-TETRAHYDROCANNABINOL, BENZODIAZEPINE RECEPTORS, MICE, DELTA-9-TETRAHYDROCANNABINOL, globus pallidus, benzodiazepines, gamma-aminobutyric acid, (+)-11-hydroxy-delta-8-dimethylheptyl-tetrahydrocannabinol, (-)-11-hydroxy-delta-8-dimethylhrptyl-tetrahydrocannabinol, (-)-delta-9-tetrahydrocannabinol, benzodiazepine receptors, mice, delta-9-tetrahydrocannabinol",
author = "Pertwee, {Roger Guy} and Wickens, {A P}",
year = "1991",
month = "3",
doi = "10.1016/0028-3908(91)90150-A",
language = "English",
volume = "30",
pages = "237--244",
journal = "Neuropharmacology",
issn = "0028-3908",
publisher = "PERGAMON-ELSEVIER SCIENCE LTD",
number = "3",

}

TY - JOUR

T1 - Enhancement by chlordiazepoxide of catalepsy induced in rats by intravenous or intrapallidal injections of enantiomeric cannabinoids

AU - Pertwee, Roger Guy

AU - Wickens, A P

PY - 1991/3

Y1 - 1991/3

N2 - The cataleptic response of rats to (-)-delta-9-tetrahydrocannabinol (delta-9-THC), measured using a bar test, was enhanced by subcutaneous pretreatment with chlordiazepoxide (10 mg/kg). Significant potentiation was observed when the cannabinoid was administered peripherally (0.1-1.0 mg/kg i.v.) and when it was injected bilaterally into sites in or very near the posterior medial region of the globus pallidus (30-mu-g). Similar results were obtained with (-)-11-hydroxy-delta-8-dimethylheptyl-THC (0.005 to 0.02 mg/kg i.v. and 3, 10 or 30-mu-g intracerebrally). However, the (+) isomer of the 11-hydroxy compound was inactive in the presence and absence of chlordiazepoxide. It was also found that chlordiazepoxide (10 mg/kg s.c.) enhanced the cataleptic response to the GABA agonist, THIP (0.25-mu-g), injected bilaterally into sites located in or very near the globus pallidus and that the cataleptic response to delta-9-THC (1 mg/kg i.v.) could be potentiated by chlordiazepoxide (50-mu-g), when this was injected into similar sites in the brain. The results support the hypothesis that the cataleptic response to cannabinoids is mediated by gamma-aminobutyric acid. They also provide evidence that cannabinoids can produce catalepsy by interacting with tissue in the vicinity of the globus pallidus and that the ability to interact in this way depends on the conformation of the cannabinoid molecule.

AB - The cataleptic response of rats to (-)-delta-9-tetrahydrocannabinol (delta-9-THC), measured using a bar test, was enhanced by subcutaneous pretreatment with chlordiazepoxide (10 mg/kg). Significant potentiation was observed when the cannabinoid was administered peripherally (0.1-1.0 mg/kg i.v.) and when it was injected bilaterally into sites in or very near the posterior medial region of the globus pallidus (30-mu-g). Similar results were obtained with (-)-11-hydroxy-delta-8-dimethylheptyl-THC (0.005 to 0.02 mg/kg i.v. and 3, 10 or 30-mu-g intracerebrally). However, the (+) isomer of the 11-hydroxy compound was inactive in the presence and absence of chlordiazepoxide. It was also found that chlordiazepoxide (10 mg/kg s.c.) enhanced the cataleptic response to the GABA agonist, THIP (0.25-mu-g), injected bilaterally into sites located in or very near the globus pallidus and that the cataleptic response to delta-9-THC (1 mg/kg i.v.) could be potentiated by chlordiazepoxide (50-mu-g), when this was injected into similar sites in the brain. The results support the hypothesis that the cataleptic response to cannabinoids is mediated by gamma-aminobutyric acid. They also provide evidence that cannabinoids can produce catalepsy by interacting with tissue in the vicinity of the globus pallidus and that the ability to interact in this way depends on the conformation of the cannabinoid molecule.

KW - GLOBUS PALLIDUS

KW - BENZODIAZEPINES

KW - GAMMA-AMINOBUTYRIC ACID

KW - (+)-11-HYDROXY-DELTA-8-DIMETHYLHEPTYL-TETRAHYDROCANNABINOL

KW - (-)-11-HYDROXY-DELTA-8-DIMETHYLHEPTYL-TETRAHYDROCANNABINOL

KW - (-)-DELTA-9-TETRAHYDROCANNABINOL

KW - BENZODIAZEPINE RECEPTORS

KW - MICE

KW - DELTA-9-TETRAHYDROCANNABINOL

KW - globus pallidus

KW - benzodiazepines

KW - gamma-aminobutyric acid

KW - (+)-11-hydroxy-delta-8-dimethylheptyl-tetrahydrocannabinol

KW - (-)-11-hydroxy-delta-8-dimethylhrptyl-tetrahydrocannabinol

KW - (-)-delta-9-tetrahydrocannabinol

KW - benzodiazepine receptors

KW - mice

KW - delta-9-tetrahydrocannabinol

U2 - 10.1016/0028-3908(91)90150-A

DO - 10.1016/0028-3908(91)90150-A

M3 - Article

VL - 30

SP - 237

EP - 244

JO - Neuropharmacology

JF - Neuropharmacology

SN - 0028-3908

IS - 3

ER -